103 related articles for article (PubMed ID: 12492902)
1. Structural characterization of peptide fragments from hCD81-LEL.
Dhanasekaran M; Baures PW; VanCompernolle S; Todd S; Prakash O
J Pept Res; 2003 Feb; 61(2):80-9. PubMed ID: 12492902
[TBL] [Abstract][Full Text] [Related]
2. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
3. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP
World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776
[TBL] [Abstract][Full Text] [Related]
4. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
[TBL] [Abstract][Full Text] [Related]
5. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.
Higginbottom A; Quinn ER; Kuo CC; Flint M; Wilson LH; Bianchi E; Nicosia A; Monk PN; McKeating JA; Levy S
J Virol; 2000 Apr; 74(8):3642-9. PubMed ID: 10729140
[TBL] [Abstract][Full Text] [Related]
6. Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81.
Drummer HE; Wilson KA; Poumbourios P
J Virol; 2002 Nov; 76(21):11143-7. PubMed ID: 12368358
[TBL] [Abstract][Full Text] [Related]
7. Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81.
Cao J; Liao XL; Wu SM; Zhao P; Zhao LJ; Wu WB; Qi ZT
J Microbiol Methods; 2007 Mar; 68(3):601-4. PubMed ID: 17178166
[TBL] [Abstract][Full Text] [Related]
8. Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.
Drummer HE; Wilson KA; Poumbourios P
Biochem Biophys Res Commun; 2005 Mar; 328(1):251-7. PubMed ID: 15670777
[TBL] [Abstract][Full Text] [Related]
9. Architecture of the hepatitis C virus E1 glycoprotein transmembrane domain studied by NMR.
Zazrin H; Shaked H; Chill JH
Biochim Biophys Acta; 2014 Mar; 1838(3):784-92. PubMed ID: 24192053
[TBL] [Abstract][Full Text] [Related]
10. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.
Masciopinto F; Campagnoli S; Abrignani S; Uematsu Y; Pileri P
Virus Res; 2001 Nov; 80(1-2):1-10. PubMed ID: 11597743
[TBL] [Abstract][Full Text] [Related]
11. Identification and expression of human CD81 gene on murine NIH/3T3 cell membrane.
Cao J; Zhao P; Zhao LJ; Wu SM; Zhu SY; Qi ZT
J Microbiol Methods; 2003 Jul; 54(1):81-5. PubMed ID: 12732424
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.
Flint M; Maidens C; Loomis-Price LD; Shotton C; Dubuisson J; Monk P; Higginbottom A; Levy S; McKeating JA
J Virol; 1999 Aug; 73(8):6235-44. PubMed ID: 10400713
[TBL] [Abstract][Full Text] [Related]
13. Structure-function analysis of hepatitis C virus envelope-CD81 binding.
Petracca R; Falugi F; Galli G; Norais N; Rosa D; Campagnoli S; Burgio V; Di Stasio E; Giardina B; Houghton M; Abrignani S; Grandi G
J Virol; 2000 May; 74(10):4824-30. PubMed ID: 10775621
[TBL] [Abstract][Full Text] [Related]
14. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein.
Nozaki A; Ikeda M; Naganuma A; Nakamura T; Inudoh M; Tanaka K; Kato N
J Biol Chem; 2003 Mar; 278(12):10162-73. PubMed ID: 12522210
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibition of hepatitis C virus E2 binding to CD81.
VanCompernolle SE; Wiznycia AV; Rush JR; Dhanasekaran M; Baures PW; Todd SC
Virology; 2003 Sep; 314(1):371-80. PubMed ID: 14517089
[TBL] [Abstract][Full Text] [Related]
16. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
[TBL] [Abstract][Full Text] [Related]
17. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.
Roccasecca R; Ansuini H; Vitelli A; Meola A; Scarselli E; Acali S; Pezzanera M; Ercole BB; McKeating J; Yagnik A; Lahm A; Tramontano A; Cortese R; Nicosia A
J Virol; 2003 Feb; 77(3):1856-67. PubMed ID: 12525620
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of recombinant human CD81 produced in Pichia pastoris.
Jamshad M; Rajesh S; Stamataki Z; McKeating JA; Dafforn T; Overduin M; Bill RM
Protein Expr Purif; 2008 Feb; 57(2):206-16. PubMed ID: 18061478
[TBL] [Abstract][Full Text] [Related]
19. Binding of hepatitis C virus to CD81.
Pileri P; Uematsu Y; Campagnoli S; Galli G; Falugi F; Petracca R; Weiner AJ; Houghton M; Rosa D; Grandi G; Abrignani S
Science; 1998 Oct; 282(5390):938-41. PubMed ID: 9794763
[TBL] [Abstract][Full Text] [Related]
20. Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81.
Cao J; Zhao P; Miao XH; Zhao LJ; Xue LJ; Qi Zt Zt
Cell Res; 2003 Dec; 13(6):473-9. PubMed ID: 14728804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
